Company profile for NanOlogy

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

NanOlogy LLC is a clinical-stage oncology company developing a submicron particle therapeutic platform designed for targeted delivery to increase the effectiveness of cancer treatment while reducing the serious adverse effects normally associated with systemic chemotherapy. Preclinical and clinical research is underway in multiple therapeutic areas to evaluate targeted delivery of concentrated, sustained cancer-killing agents ...
NanOlogy LLC is a clinical-stage oncology company developing a submicron particle therapeutic platform designed for targeted delivery to increase the effectiveness of cancer treatment while reducing the serious adverse effects normally associated with systemic chemotherapy. Preclinical and clinical research is underway in multiple therapeutic areas to evaluate targeted delivery of concentrated, sustained cancer-killing agents to solid tumors to destroy the cancer locally without collateral damage to the body and to stimulate an antitumoral immune response to attack metastatic disease without adding to systemic toxicity.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3909 Hulen Street Fort Worth, Texas 76107
Telephone
Telephone
(817) 900-4002
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/nanology-appoints-david-j-arthur-as-chief-executive-officer-to-drive-clinical-development-of-its-large-surface-area-microparticle-lsam-investigational-drug-portfolio-302644316.html

PR NEWSWIRE
17 Dec 2025

https://www.prnewswire.com/news-releases/nanology-unveils-drug-development-program-for-rare-pediatric-brainstem-tumor-302638879.html

PR NEWSWIRE
11 Dec 2025

https://www.businesswire.com/news/home/20231219196598/en

BUSINESSWIRE
19 Dec 2023

https://www.businesswire.com/news/home/20231010850022/en

BUSINESSWIRE
10 Oct 2023

https://www.businesswire.com/news/home/20230607005024/en

BUSINESSWIRE
07 Jun 2023

https://www.businesswire.com/news/home/20230307005153/en

BUSINESSWIRE
07 Mar 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty